Alison Galvani






Galvani AP, Fitzpatrick MC. (2020). Cost-effectiveness of transitional US plans for universal health care. Lancet, 395(10238)

Du Z, Xu X, Wang L, Fox SJ, Cowling BJ, Galvani AP, Meyers LA. (2020). Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities. medRxiv : the preprint server for health sciences

Wells CR, Huppert A, Fitzpatrick MC, Pandey A, Velan B, Singer BH, Bauch CT, Galvani AP. (2020). Prosocial polio vaccination in Israel. Proceedings of the National Academy of Sciences of the United States of America

Abdollahi E, Champredon D, Langley JM, Galvani AP, Moghadas SM. (2020). Temporal estimates of case-fatality rate for COVID-19 outbreaks in Canada and the United States. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Castaño MS, Ndeffo-Mbah ML, Rock KS, Palmer C, Knock E, Mwamba Miaka E, Ndung'u JM, Torr S, Verlé P, Spencer SEF, Galvani A, Bever C, Keeling MJ, Chitnis N. (2020). Assessing the impact of aggregating disease stage data in model predictions of human African trypanosomiasis transmission and control activities in Bandundu province (DRC). PLoS neglected tropical diseases, 14(1)

Wells CR, Fitzpatrick MC, Sah P, Shoukat A, Pandey A, El-Sayed AM, Singer BH, Moghadas SM, Galvani AP. (2020). Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA. The Lancet. Infectious diseases

Galvani AP, Parpia AS, Pandey A, Zimmer C, Kahn JG, Fitzpatrick MC. (2020). The imperative for universal healthcare to curtail the COVID-19 outbreak in the USA. EClinicalMedicine

Galvani AP, Parpia AS, Foster EM, Singer BH, Fitzpatrick MC. (2020). Improving the prognosis of health care in the USA. Lancet, 395(10223)

Wells CR, Sah P, Moghadas SM, Pandey A, Shoukat A, Wang Y, Wang Z, Meyers LA, Singer BH, Galvani AP. (2020). Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak. Proceedings of the National Academy of Sciences of the United States of America

Boyko RH, Marie Harrison L, Humphries D, Galvani AP, Townsend JP, Otchere J, Wilson MD, Cappello M. (2020). Dogs and pigs are transport hosts of Necator americanus: Molecular evidence for a zoonotic mechanism of human hookworm transmission in Ghana. Zoonoses and public health

Du Z, Xu X, Wang L, Fox SJ, Cowling BJ, Galvani AP, Meyers LA. (2020). Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China. Emerging infectious diseases, 26(9)

Shoukat A, Wells CR, Langley JM, Singer BH, Galvani AP. (2020). Projecting demand for critical care beds during COVID-19 outbreaks in Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Wells CR, Stearns JK, Lutumba P, Galvani AP. (2020). COVID-19 on the African continent. The Lancet. Infectious diseases

Moghadas SM, Shoukat A, Fitzpatrick MC, Wells CR, Sah P, Pandey A, Sachs JD, Wang Z, Meyers LA, Singer BH, Galvani AP. (2020). Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proceedings of the National Academy of Sciences of the United States of America

Du Z, Nugent C, Galvani AP, Krug RM, Meyers LA. (2020). Modeling mitigation of influenza epidemics by baloxavir. Nature communications, 11(1)

Champredon D, Shoukat A, Singer BH, Galvani AP, Moghadas SM. (2020). Curbing the 2019 Samoa measles outbreak. The Lancet. Infectious diseases, 20(3)

Pandey A, Galvani AP. (2019). Quantifying risk factors to guide progress towards leprosy elimination. The Lancet. Global health, 7(9)

Fitzpatrick MC, Bauch CT, Townsend JP, Galvani AP. (2019). Modelling microbial infection to address global health challenges. Nature microbiology, 4(10)

Pandey A, Galvani AP. (2019). The global burden of HIV and prospects for control. The lancet. HIV

Beyene TJ, Fitzpatrick MC, Galvani AP, Mourits MCM, Revie CW, Cernicchiaro N, Sanderson MW, Hogeveen H. (2019). Impact of One-Health framework on vaccination cost-effectiveness: A case study of rabies in Ethiopia. One health (Amsterdam, Netherlands), (8)

Thomson N, Littlejohn M, Strathdee SA, Southby RF, Coghlan B, Rosenfeld JV, Galvani AP. (2019). Harnessing synergies at the interface of public health and the security sector. Lancet, 393(10168)

Pandey A, Fitzpatrick MC, Galvani AP. (2019). Metrics and benchmarks for HIV transition - Authors' reply. The lancet. HIV, 6(3)

Wells CR, Pandey A, Parpia AS, Fitzpatrick MC, Meyers LA, Singer BH, Galvani AP. (2019). Ebola vaccination in the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences of the United States of America, 116(20)

King CH, Galvani AP. (2018). Underestimation of the global burden of schistosomiasis. Lancet, 391(10118)

Grantz KH, Chabaari W, Samuel RK, Gershom B, Blum L, Worden L, Ackley S, Liu F, Lietman TM, Galvani AP, Prajna L, Porco TC. (2018). Spatial distribution of leprosy in India: an ecological study. Infectious diseases of poverty, 7(1)

Fitzpatrick MC, Gray GE, Galvani AP. (2018). The Challenge of Vanquishing HIV for the Next Generation-Facing the Future. JAMA pediatrics, 172(7)

Ndeffo-Mbah ML, Vigliotti VS, Skrip LA, Dolan K, Galvani AP. (2018). Dynamic Models of Infectious Disease Transmission in Prisons and the General Population. Epidemiologic reviews, 40(1)

Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP. (2018). Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study. The lancet. HIV, 5(9)

Bartsch SM, Asti L, Cox SN, Durham DP, Randall S, Hotez PJ, Galvani AP, Lee BY. (2019). What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?. The Journal of infectious diseases, 220(6)

Galvani AP, Pandey A, Fitzpatrick MC, Medlock J, Gray GE. (2018). Defining control of HIV epidemics. The lancet. HIV, 5(11)

Durham DP, Fitzpatrick MC, Ndeffo-Mbah ML, Parpia AS, Michael NL, Galvani AP. (2018). Evaluating Vaccination Strategies for Zika Virus in the Americas. Annals of internal medicine, 168(9)

Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP. (2018). Optimizing the impact of low-efficacy influenza vaccines. Proceedings of the National Academy of Sciences of the United States of America, 115(20)

Bartsch SM, Avelis CM, Asti L, Hertenstein DL, Ndeffo-Mbah M, Galvani A, Lee BY. (2018). The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission. PLoS neglected tropical diseases, 12(11)

Lee BY, Bartsch SM, Skrip L, Hertenstein DL, Avelis CM, Ndeffo-Mbah M, Tilchin C, Dumonteil EO, Galvani A. (2018). Are the London Declaration's 2020 goals sufficient to control Chagas disease?: Modeling scenarios for the Yucatan Peninsula. PLoS neglected tropical diseases, 12(3)

Sah P, Fitzpatrick MC, Pandey A, Galvani AP. (2017). HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'. AIDS (London, England), 31(17)

Medlock J, Pandey A, Parpia AS, Tang A, Skrip LA, Galvani AP. (2017). Effectiveness of UNAIDS targets and HIV vaccination across 127 countries. Proceedings of the National Academy of Sciences of the United States of America, 114(15)

Galvani AP, Durham DP, Vermund SH, Fitzpatrick MC. (2017). California Universal Health Care Bill: an economic stimulus and life-saving proposal. Lancet, 390(10106)

Skrip LA, Fallah MP, Gaffney SG, Yaari R, Yamin D, Huppert A, Bawo L, Nyenswah T, Galvani AP. (2017). Characterizing risk of Ebola transmission based on frequency and type of case-contact exposures. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 372(1721)

Galvani AP, Fitzpatrick MC, Vermund SH, Singer BH. (2017). Fund global health: Save lives and money. Science (New York, N.Y.), 356(6342)

Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP. (2017). Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee. Lancet, 390(10110)

Castro LA, Fox SJ, Chen X, Liu K, Bellan SE, Dimitrov NB, Galvani AP, Meyers LA. (2017). Assessing real-time Zika risk in the United States. BMC infectious diseases, 17(1)

Lee BY, Alfaro-Murillo JA, Parpia AS, Asti L, Wedlock PT, Hotez PJ, Galvani AP. (2017). The potential economic burden of Zika in the continental United States. PLoS neglected tropical diseases, 11(4)

Alsallaq RA, Gurarie D, Ndeffo Mbah M, Galvani A, King C. (2017). Quantitative assessment of the impact of partially protective anti-schistosomiasis vaccines. PLoS neglected tropical diseases, 11(4)

Blok DJ, Crump RE, Sundaresh R, Ndeffo-Mbah M, Galvani AP, Porco TC, de Vlas SJ, Medley GF, Richardus JH. (2017). Forecasting the new case detection rate of leprosy in four states of Brazil: A comparison of modelling approaches. Epidemics, (18)

Bartsch SM, Peterson JK, Hertenstein DL, Skrip L, Ndeffo-Mbah M, Galvani AP, Dobson AP, Lee BY. (2017). Comparison and validation of two computational models of Chagas disease: A thirty year perspective from Venezuela. Epidemics, (18)

Fallah MP, Skrip LA, Raftery P, Kullie M, Borbor W, Laney AS, Blackley DJ, Christie A, Dokubo EK, Lo TQ, Coulter S, Baller A, Vonhm BT, Bemah P, Lomax S, Yeiah A, Wapoe-Sackie Y, Mann J, Clement P, Davies-Wayne G, Hamblion E, Wolfe C, Williams D, Gasasira A, Kateh F, Nyenswah TG, Galvani AP. (2017). Bolstering Community Cooperation in Ebola Resurgence Protocols: Combining Field Blood Draw and Point-of-Care Diagnosis. PLoS medicine, 14(1)

DeAngelis H, Scarpino SV, Fitzpatrick MC, Galvani AP, Althouse BM. (2016). Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. JAMA pediatrics, 170(5)

Pandey A, Galvani A. (2017). Strategies for Trypanosoma brucei gambiense elimination. The Lancet. Global health, 5(1)

Li M, Taylor EG, Atkins KE, Chapman GB, Galvani AP. (2016). Stimulating Influenza Vaccination via Prosocial Motives. PLoS One, 11(7)

Ndeffo-Mbah ML, Galvani AP. (2017). Global elimination of lymphatic filariasis. The Lancet. Infectious diseases, 17(4)

Fitzpatrick MC, Shah HA, Pandey A, Bilinski AM, Kakkar M, Clark AD, Townsend JP, Abbas SS, Galvani AP. (2016). One Health approach to cost-effective rabies control in India. Proceedings of the National Academy of Sciences of the United States of America, 113(51)

Durham DP, Ndeffo-Mbah ML, Skrip LA, Jones FK, Bauch CT, Galvani AP. (2016). National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States. Proceedings of the National Academy of Sciences of the United States of America, 113(18)

Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP. (2016). Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine, 34(29)

Ndeffo-Mbah ML, Parpia AS, Galvani AP. (2016). Mitigating Prenatal Zika Virus Infection in the Americas. Annals of internal medicine, 165(8)

Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. (2016). Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerging infectious diseases, 22(3)

Atkins KE, Fitzpatrick MC, Galvani AP, Townsend JP. (2016). Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. American journal of epidemiology, 183(12)

Fallah MP, Skrip LA, Dahn BT, Nyenswah TG, Flumo H, Glayweon M, Lorseh TL, Kaler SG, Higgs ES, Galvani AP. (2016). Pregnancy outcomes in Liberian women who conceived after recovery from Ebola virus disease. The Lancet. Global health, 4(10)

Bilinski AM, Fitzpatrick MC, Rupprecht CE, Paltiel AD, Galvani AP. (2016). Optimal frequency of rabies vaccination campaigns in Sub-Saharan Africa. Proceedings. Biological sciences, 283(1842)

Yamin D, Atkins KE, Remy V, Galvani AP. (2016). Cost-Effectiveness of Rotavirus Vaccination in France-Accounting for Indirect Protection. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 19(6)

Galvani AP, Bauch CT, Anand M, Singer BH, Levin SA. (2016). Human-environment interactions in population and ecosystem health. Proceedings of the National Academy of Sciences of the United States of America, 113(51)

Eggo RM, Scott JG, Galvani AP, Meyers LA. (2016). Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model. Proceedings of the National Academy of Sciences of the United States of America, 113(8)

Macarayan E, Ndeffo-Mbah M, Beyrer C, Galvani AP. (2016). Philippine drug war and impending public health crisis. Lancet, 388(10062)

Fallah M, Dahn B, Nyenswah TG, Massaquoi M, Skrip LA, Yamin D, Mbah MN, Joe N, Freeman S, Harris T, Benson Z, Galvani AP. (2016). Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Annals of internal medicine, 164(5)

Ndeffo-Mbah ML, Durham DP, Skrip LA, Nsoesie EO, Brownstein JS, Fish D, Galvani AP. (2016). Evaluating the effectiveness of localized control strategies to curtail chikungunya. Scientific reports, (6)

Yamin D, Jones FK, DeVincenzo JP, Gertler S, Kobiler O, Townsend JP, Galvani AP. (2016). Vaccination strategies against respiratory syncytial virus. Proceedings of the National Academy of Sciences of the United States of America, 113(46)

Atkins KE, Pandey A, Wenzel NS, Skrip L, Yamin D, Nyenswah TG, Fallah M, Bawo L, Medlock J, Altice FL, Townsend J, Ndeffo-Mbah ML, Galvani AP. (2016). Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. The American journal of tropical medicine and hygiene, 94(4)

Skrip LA, Galvani AP. (2016). Next Steps for Ebola Vaccination: Deployment in Non-Epidemic, High-Risk Settings. PLoS neglected tropical diseases, 10(8)

Herrera JL, Srinivasan R, Brownstein JS, Galvani AP, Meyers LA. (2016). Disease Surveillance on Complex Social Networks. PLoS computational biology, 12(7)

Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP. (2016). Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. PLoS neglected tropical diseases, 10(3)

Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. (2016). Cost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South Africa. PLoS One, 11(12)

Alfaro-Murillo JA, Parpia AS, Fitzpatrick MC, Tamagnan JA, Medlock J, Ndeffo-Mbah ML, Fish D, Ávila-Agüero ML, Marín R, Ko AI, Galvani AP. (2016). A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control. PLoS neglected tropical diseases, 10(5)

Wells CR, Galvani AP. (2015). Public health impact of disease-behavior dynamics: Comment on "Coupled disease-behavior dynamics on complex networks: A review" by Z. Wang et al. Physics of life reviews, (15)

Singh B, Huang HC, Morton DP, Johnson GP, Gutfraind A, Galvani AP, Clements B, Meyers LA. (2015). Optimizing distribution of pandemic influenza antiviral drugs. Emerging infectious diseases, 21(2)

Ndeffo Mbah ML, Parikh S, Galvani AP. (2015). Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan Africa. The American journal of tropical medicine and hygiene, 92(3)

Gutfraind A, Galvani AP, Meyers LA. (2015). Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection. JAMA pediatrics, 169(4)

Brook CE, Beauclair R, Ngwenya O, Worden L, Ndeffo-Mbah M, Lietman TM, Satpathy SK, Galvani AP, Porco TC. (2015). Spatial heterogeneity in projected leprosy trends in India. Parasites & vectors, (8)

Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, Aurelio HO, Ferro J, Galvani AP, King CH. (2015). Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasites & vectors, (8)

Bellan SE, Pulliam JR, Pearson CA, Champredon D, Fox SJ, Skrip L, Galvani AP, Gambhir M, Lopman BA, Porco TC, Meyers LA, Dushoff J. (2015). Statistical power and validity of Ebola vaccine trials in Sierra Leone: a simulation study of trial design and analysis. The Lancet. Infectious diseases, 15(6)

Yamin D, Gertler S, Ndeffo-Mbah ML, Galvani AP. (2015). Effect of Ebola progression in Liberia. Annals of internal medicine, 162(10)

Taylor E, Atkins KE, Medlock J, Li M, Chapman GB, Galvani AP. (2016). Cross-Cultural Household Influence on Vaccination Decisions. Medical decision making : an international journal of the Society for Medical Decision Making, 36(7)

Greenhalgh S, Galvani AP, Medlock J. (2015). Disease elimination and re-emergence in differential-equation models. Journal of theoretical biology, (387)

Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. (2015). Under-reporting and case fatality estimates for emerging epidemics. BMJ (Clinical research ed.), (350)

Nsoesie EO, Ricketts RP, Brown HE, Fish D, Durham DP, Ndeffo Mbah ML, Christian T, Ahmed S, Marcellin C, Shelly E, Owers K, Wenzel N, Galvani AP, Brownstein JS. (2015). Spatial and Temporal Clustering of Chikungunya Virus Transmission in Dominica. PLoS neglected tropical diseases, 9(8)

Fallah M, Skrip LA, d'Harcourt E, Galvani AP. (2015). Strategies to prevent future Ebola epidemics. Lancet, 386(9989)

Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Basáñez MG, Behrend M, Blok DJ, Chapman LA, Coffeng L, Courtenay O, Crump RE, de Vlas SJ, Dobson A, Dyson L, Farkas H, Galvani AP, Gambhir M, Gurarie D, Irvine MA, Jervis S, Keeling MJ, Kelly-Hope L, King C, Lee BY, Le Rutte EA, Lietman TM, Ndeffo-Mbah M, Medley GF, Michael E, Pandey A, Peterson JK, Pinsent A, Porco TC, Richardus JH, Reimer L, Rock KS, Singh BK, Stolk W, Swaminathan S, Torr SJ, Townsend J, Truscott J, Walker M, Zoueva A, . (2015). Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites & vectors, (8)

Alfaro-Murillo JA, Townsend JP, Galvani AP. (2016). Optimizing age of cytomegalovirus screening and vaccination to avert congenital disease in the US. Vaccine, 34(2)

Gilbert JA, Long EF, Brooks RP, Friedland GH, Moll AP, Townsend JP, Galvani AP, Shenoi SV. (2015). Integrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South Africa. PloS one, 10(5)

Ibuka Y, Ohkusa Y, Sugawara T, Chapman GB, Yamin D, Atkins KE, Taniguchi K, Okabe N, Galvani AP. (2016). Social contacts, vaccination decisions and influenza in Japan. Journal of epidemiology and community health, 70(2)

Bellan SE, Dushoff J, Galvani AP, Meyers LA. (2015). Reassessment of HIV-1 acute phase infectivity: accounting for heterogeneity and study design with simulated cohorts. PLoS medicine, 12(3)

Fallah MP, Skrip LA, Gertler S, Yamin D, Galvani AP. (2015). Quantifying Poverty as a Driver of Ebola Transmission. PLoS neglected tropical diseases, 9(12)

Townsend JP, Skrip LA, Galvani AP. (2015). Impact of bed capacity on spatiotemporal shifts in Ebola transmission. Proceedings of the National Academy of Sciences of the United States of America, 112(46)

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. (2015). Harnessing case isolation and ring vaccination to control Ebola. PLoS neglected tropical diseases, 9(5)

Wells C, Yamin D, Ndeffo-Mbah ML, Wenzel N, Gaffney SG, Townsend JP, Meyers LA, Fallah M, Nyenswah TG, Altice FL, Atkins KE, Galvani AP. (2015). Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLoS neglected tropical diseases, 9(6)

Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP. (2015). Effect of Ebola progression on transmission and control in Liberia. Annals of internal medicine, 162(1)

Ibuka Y, Li M, Vietri J, Chapman GB, Galvani AP. (2014). Free-riding behavior in vaccination decisions: an experimental study. PLoS One, 9(1)

Galvani AP, Ndeffo-Mbah ML, Wenzel N, Childs JE. (2014). Ebola vaccination: if not now, when?. Annals of internal medicine, 161(10)

Pandey A, Atkins KE, Medlock J, Wenzel N, Townsend JP, Childs JE, Nyenswah TG, Ndeffo-Mbah ML, Galvani AP. (2014). Strategies for containing Ebola in West Africa. Science (New York, N.Y.), 346(6212)

Fitzpatrick MC, Hampson K, Cleaveland S, Mzimbiri I, Lankester F, Lembo T, Meyers LA, Paltiel AD, Galvani AP. (2014). Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Annals of internal medicine, 160(2)

Scarpino SV, Iamarino A, Wells C, Yamin D, Ndeffo-Mbah M, Wenzel NS, Fox SJ, Nyenswah T, Altice FL, Galvani AP, Meyers LA, Townsend JP. (2015). Epidemiological and viral genomic sequence analysis of the 2014 ebola outbreak reveals clustered transmission. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60(7)

Skene KJ, Paltiel AD, Shim E, Galvani AP. (2014). A marginal benefit approach for vaccinating influenza "superspreaders". Medical decision making : an international journal of the Society for Medical Decision Making, 34(4)

Yamin D, Balicer RD, Galvani AP. (2014). Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine, 32(33)

Greenhalgh S, Ndeffo M, Galvani AP, Parikh S. (2015). The epidemiological impact of HIV antiretroviral therapy on malaria in children. AIDS (London, England), 29(4)

Gilbert JA, Meyers LA, Galvani AP, Townsend JP. (2014). Probabilistic uncertainty analysis of epidemiological modeling to guide public health intervention policy. Epidemics, (6)

Ndeffo Mbah ML, Skrip L, Greenhalgh S, Hotez P, Galvani AP. (2014). Impact of Schistosoma mansoni on malaria transmission in Sub-Saharan Africa. PLoS neglected tropical diseases, 8(10)

Ndeffo Mbah ML, Gilbert JA, Galvani AP. (2014). Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities. Epidemics, (7)

Lipsitch M, Galvani AP. (2014). Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS medicine, 11(5)

Lewnard JA, Ndeffo Mbah ML, Alfaro-Murillo JA, Altice FL, Bawo L, Nyenswah TG, Galvani AP. (2014). Dynamics and control of Ebola virus transmission in Montserrado, Liberia: a mathematical modelling analysis. The Lancet. Infectious diseases, 14(12)

Boni MF, Galvani AP, Wickelgren AL, Malani A. (2013). Economic epidemiology of avian influenza on smallholder poultry farms. Theoretical population biology, (90)

Ndeffo Mbah ML, Durham DP, Medlock J, Galvani AP. (2014). Country- and age-specific optimal allocation of dengue vaccines. Journal of theoretical biology, (342)

Durham DP, Ndeffo Mbah ML, Medlock J, Luz PM, Meyers LA, Paltiel AD, Galvani AP. (2013). Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine, 31(37)

Ndeffo Mbah ML, Medlock J, Meyers LA, Galvani AP, Townsend JP. (2013). Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine, 31(30)

Mbah MLN, Poolman EM, Drain PK, Coffee MP, van der Werf MJ, Galvani AP. (2013). HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Tropical medicine & international health : TM & IH, 18(10)

Ndeffo Mbah ML, Kjetland EF, Atkins KE, Poolman EM, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. (2013). Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proceedings of the National Academy of Sciences of the United States of America, 110(19)

Medlock J, Atkins KE, Thomas DN, Aksoy S, Galvani AP. (2013). Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. PLoS neglected tropical diseases, 7(8)

Atkins KE, Townsend JP, Medlock J, Galvani AP. (2013). Epidemiological mechanisms of genetic resistance to kuru. Journal of the Royal Society, Interface, 10(85)

Bauch CT, Galvani AP. (2013). Epidemiology. Social factors in epidemiology. Science (New York, N.Y.), 342(6154)

Ndeffo Mbah ML, Poolman EM, Atkins KE, Orenstein EW, Meyers LA, Townsend JP, Galvani AP. (2013). Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. PLoS neglected tropical diseases, 7(8)

Padmanabha H, Durham D, Correa F, Diuk-Wasser M, Galvani A. (2012). The interactive roles of Aedes aegypti super-production and human density in dengue transmission. PLoS neglected tropical diseases, 6(8)

Atkins KE, Shim E, Carroll S, Quilici S, Galvani AP. (2012). The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine, 30(48)

Araz OM, Galvani A, Meyers LA. (2012). Geographic prioritization of distributing pandemic influenza vaccines. Health care management science, 15(3)

Fitzpatrick MC, Hampson K, Cleaveland S, Meyers LA, Townsend JP, Galvani AP. (2012). Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS neglected tropical diseases, 6(8)

Chapman GB, Li M, Vietri J, Ibuka Y, Thomas D, Yoon H, Galvani AP. (2012). Using game theory to examine incentives in influenza vaccination behavior. Psychological science, 23(9)

Tsao K, Fish D, Galvani AP. (2012). Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector borne and zoonotic diseases (Larchmont, N.Y.), 12(7)

Araz OM, Damien P, Paltiel DA, Burke S, van de Geijn B, Galvani A, Meyers LA. (2012). Simulating school closure policies for cost effective pandemic decision making. BMC Public Health, (12)

Karan A, Chapman GB, Galvani A. (2012). The influence of poverty and culture on the transmission of parasitic infections in rural nicaraguan villages. Journal of parasitology research, (2012)

Shim E, Chapman GB, Townsend JP, Galvani AP. (2012). The influence of altruism on influenza vaccination decisions. Journal of the Royal Society, Interface, 9(74)

Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, Patel MM, Grenfell BT, Parashar UD, Lopman BA. (2012). Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One, 7(8)

Ndeffo Mbah ML, Liu J, Bauch CT, Tekel YI, Medlock J, Meyers LA, Galvani AP. (2012). The impact of imitation on vaccination behavior in social contact networks. PLoS computational biology, 8(4)

Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP. (2012). Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. The Journal of infectious diseases, 206(8)

Porco TC, Gao D, Scott JC, Shim E, Enanoria WT, Galvani AP, Lietman TM. (2012). When does overuse of antibiotics become a tragedy of the commons?. PLoS One, 7(12)

Shim E, Galvani AP. (2012). Distinguishing vaccine efficacy and effectiveness. Vaccine, 30(47)

Tekle YI, Nielsen KM, Liu J, Pettigrew MM, Meyers LA, Galvani AP, Townsend JP. (2012). Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains. PloS one, 7(12)

Hladish T, Melamud E, Barrera LA, Galvani A, Meyers LA. (2012). EpiFire: An open source C++ library and application for contact network epidemiology. BMC Bioinformatics, (13)

Ibuka Y, Paltiel AD, Galvani AP. (2012). Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Medical decision making : an international journal of the Society for Medical Decision Making, 32(3)

Cornforth DM, Reluga TC, Shim E, Bauch CT, Galvani AP, Meyers LA. (2011). Erratic flu vaccination emerges from short-sighted behavior in contact networks. PLoS computational biology, 7(1)

Shim E, Meyers LA, Galvani AP. (2011). Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health, (11 Suppl 1)

Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT. (2011). Impact of imitation processes on the effectiveness of ring vaccination. Bulletin of mathematical biology, 73(11)

Vietri JT, Chapman GB, Li M, Galvani AP. (2011). Preferences for HPV vaccination in parent-child dyads: Similarities and acknowledged differences. Preventive medicine, 52(5)

Li M, Chapman GB, Ibuka Y, Meyers LA, Galvani A. (2011). Who got vaccinated against H1N1 pandemic influenza? A longitudinal study in four U.S. cities. Psychology & health, 27(1)

Luz PM, Vanni T, Medlock J, Paltiel AD, Galvani AP. (2011). Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet, 377(9778)

Atkins KE, Shim E, Pitzer VE, Galvani AP. (2012). Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine, 30(3)

Liu J, Kochin BF, Tekle YI, Galvani AP. (2012). Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. Journal of the Royal Society, Interface, 9(66)

Volz EM, Miller JC, Galvani A, Ancel Meyers L. (2011). Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS computational biology, 7(6)

Reluga TC, Galvani AP. (2011). A general approach for population games with application to vaccination. Mathematical biosciences, 230(2)

Luz PM, Struchiner CJ, Galvani AP. (2010). Modeling transmission dynamics and control of vector-borne neglected tropical diseases. PLoS neglected tropical diseases, 4(10)

Davis S, Aksoy S, Galvani A. (2011). A global sensitivity analysis for African sleeping sickness. Parasitology, 138(4)

Ibuka Y, Chapman GB, Meyers LA, Li M, Galvani AP. (2010). The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC infectious diseases, (10)

Li M, Vietri J, Galvani AP, Chapman GB. (2010). How do people value life?. Psychological science, 21(2)

Shim E, Chapman GB, Galvani AP. (2010). Decision making with regard to antiviral intervention during an influenza pandemic. Medical decision making : an international journal of the Society for Medical Decision Making, 30(4)

Bauch CT, Li M, Chapman G, Galvani AP. (2010). Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?. The Lancet. Infectious diseases, 10(2)

Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. (2009). Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. The Lancet. Infectious diseases, 9(3)

Basu S, Galvani AP. (2009). The evolution of tuberculosis virulence. Bulletin of mathematical biology, 71(5)

Shim E, Galvani AP. (2009). Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine, 27(30)

Medlock J, Galvani AP. (2009). Optimizing influenza vaccine distribution. Science (New York, N.Y.), 325(5948)

Shim E, Hampson K, Cleaveland S, Galvani AP. (2009). Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine, 27(51)

Basu S, Friedland GH, Medlock J, Andrews JR, Shah NS, Gandhi NR, Moll A, Moodley P, Sturm AW, Galvani AP. (2009). Averting epidemics of extensively drug-resistant tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 106(18)

Shim E, Galvani AP. (2009). Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One, 4(5)

Medlock J, Luz PM, Struchiner CJ, Galvani AP. (2009). The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. The American naturalist, 174(4)

Medlock J, Meyers LA, Galvani A. (2009). Optimizing allocation for a delayed influenza vaccination campaign. PLoS currents, (1)

Reluga TC, Medlock J, Galvani A. (2009). The discounted reproductive number for epidemiology. Mathematical biosciences and engineering : MBE, 6(2)

Shim E, Kochin B, Galvani A. (2009). Insights from epidemiological game theory into gender-specific vaccination against rubella. Mathematical biosciences and engineering : MBE, 6(4)

Basu S, Orenstein E, Galvani AP. (2008). The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. The Journal of infectious diseases, 198(10)

Basu S, Chapman GB, Galvani AP. (2008). Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proceedings of the National Academy of Sciences of the United States of America, 105(48)

Poolman EM, Elbasha EH, Galvani AP. (2008). Vaccination and the evolutionary ecology of human papillomavirus. Vaccine, (26 Suppl 3)

Day T, Galvani A, Struchiner C, Gumel A. (2008). The evolutionary consequences of vaccination. Vaccine, (26 Suppl 3)

Luz PM, Mendes BV, Codeço CT, Struchiner CJ, Galvani AP. (2008). Time series analysis of dengue incidence in Rio de Janeiro, Brazil. The American journal of tropical medicine and hygiene, 79(6)

Basu S, Galvani AP. (2007). Re: "Multiparameter calibration of a natural history model of cervical cancer". American journal of epidemiology, 166(8)

Basu S, Andrews JR, Poolman EM, Gandhi NR, Shah NS, Moll A, Moodley P, Galvani AP, Friedland GH. (2007). Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet, 370(9597)

Basu S, Galvani AP. (2007). Extensively drug-resistant tuberculosis in South Africa. Lancet, 369(9558)

Galvani AP, Reluga TC, Chapman GB. (2007). Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings of the National Academy of Sciences of the United States of America, 104(13)

Reluga TC, Medlock J, Poolman E, Galvani AP. (2007). Optimal timing of disease transmission in an age-structured population. Bulletin of mathematical biology, 69(8)

Reluga TC, Bauch CT, Galvani AP. (2006). Evolving public perceptions and stability in vaccine uptake. Mathematical biosciences, 204(2)

Galvani AP, Medlock J, Chapman GB. (2006). The ethics of influenza vaccination. Science (New York, N.Y.), 313(5788)

Poolman EM, Galvani AP. (2007). Evaluating candidate agents of selective pressure for cystic fibrosis. Journal of the Royal Society, Interface, 4(12)

Poolman EM, Galvani AP. (2006). Modeling targeted ivermectin treatment for controlling river blindness. The American journal of tropical medicine and hygiene, 75(5)

Reluga TC, Medlock J, Galvani AP. (2006). A model of spatial epidemic spread when individuals move within overlapping home ranges. Bulletin of mathematical biology, 68(2)

Galvani AP, May RM. (2005). Epidemiology: dimensions of superspreading. Nature, 438(7066)

Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP. (2005). Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (Cambridge, Mass.), 16(6)

Elbasha EH, Galvani AP. (2005). Vaccination against multiple HPV types. Mathematical biosciences, 197(1)

Galvani AP. (2005). The role of mutation accumulation in HIV progression. Proceedings. Biological sciences, 272(1574)

Galvani AP, Novembre J. (2005). The evolutionary history of the CCR5-Delta32 HIV-resistance mutation. Microbes and infection, 7(2)

Galvani AP. (2005). Age-dependent epidemiological patterns and strain diversity in helminth parasites. The Journal of parasitology, 91(1)

Porco TC, Lloyd-Smith JO, Gross KL, Galvani AP. (2005). The effect of treatment on pathogen virulence. Journal of theoretical biology, 233(1)

Galvani AP, Slatkin M. (2004). Intense selection in an age-structured population. Proceedings. Biological sciences, 271(1535)

Galvani AP. (2004). Emerging infections: what have we learned from SARS?. Emerging infectious diseases, 10(7)

Ferguson NM, Galvani AP, Bush RM. (2003). Ecological and immunological determinants of influenza evolution. Nature, 422(6930)

Galvani AP, Coleman RM, Ferguson NM. (2003). The maintenance of sex in parasites. Proceedings. Biological sciences, 270(1510)

Lloyd-Smith JO, Galvani AP, Getz WM. (2003). Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proceedings. Biological sciences, 270(1528)

Bauch CT, Galvani AP. (2003). Using network models to approximate spatial point-process models. Mathematical biosciences, 184(1)

Galvani AP, Slatkin M. (2003). Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proceedings of the National Academy of Sciences of the United States of America, 100(25)

Galvani AP, Lei X, Jewell NP. (2003). Severe acute respiratory syndrome: temporal stability and geographic variation in case-fatality rates and doubling times. Emerging infectious diseases, 9(8)

Galvani AP. (2003). Immunity, antigenic heterogeneity, and aggregation of helminth parasites. The Journal of parasitology, 89(2)